What's happening to the Slater & Gordon Limited share price?

The Slater & Gordon Limited (ASX:SGH) share price surged higher on Monday.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of Slater & Gordon Limited (ASX: SGH) were back on top on Monday after the listed law firm confirmed to the ASX that it was in compliance with its listing requirements.

Slater & Gordon's share price closed at 89.5 cents on Monday, up 7.8% compared to the previous closing price but down 89% since they peaked above $8 a share in April this year. Their current price is also more than 19% above the 75 cent price target Deutsche Bank recently gave the shares.

The law firm was yesterday forced to respond to a query by the market regulator, the Australian Securities Exchange, in which it confirmed it was still in compliance with its continuous disclosure obligations. This query was in relation to Slater & Gordon's most recent announcement in which it said its earnings guidance for the 2016 financial year (which had been provided less than three weeks prior) was now being reconsidered.

What happened?

Yesterday's response to the ASX query suggests that the group was still confident it could hit its 2016 financial year earnings targets as at 30 November, but became aware of information related to its British business indicating worse-than-expected performance results late on Wednesday 9 December.

Slater & Gordon said that this draft information was internal management information "which, without verification, was insufficiently definite to warrant disclosure." Clarification, verification and confirmation of the information was completed on the night of Wednesday 16 December, communicated to the board the following morning and then to investors before the market opened on Thursday 17 December.

While Slater & Gordon looks to have cleared the air surrounding its continuous disclosure obligations (which investors clearly appreciated on Monday), there is still plenty of uncertainty surrounding the group.

For starters, it is subject to two major investigations by regulators in the United Kingdom and Australia related to its accounting practices, two potential class actions and there's the potential for impairments to goodwill related to its controversial acquisition of Quindell Plc's Professional Services Division earlier this year.

What's more, some experts think this write-down of goodwill could spark an "emergency" capital raising, according to The Australian Financial Review, together with a reduction in dividends to avoid breaching its debt covenants.

Should you buy?

Slater & Gordon has had a dreadful year and there is still plenty of uncertainty lingering over the company's head. Although much of this is likely already priced into the shares, it's still possible the shares could have even further to fall. While they might seem cheap, I'm certainly not a buyer yet.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »